Educational research on US and Indian equities, ETFs, mutual funds and crypto, with screeners and a free investing academy.
All data is for educational purposes only and should not be considered investment advice.
Equiscale is operated by Syntellia LLC, a Delaware limited liability company.
© 2026 Syntellia LLC. All rights reserved.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Rule-based from financial data. Not advice.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 5 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $3.3B | $-738M | $-1.1B | $-440M | -56.6% | 5.0% | -531.4% |
| 2024 | $3.2B | $608M | $256M | $-561M | 8.3% | 7.7% | -1279.7% |
| 2023 | $2.9B | $189M | $-22M | $38M | -0.8% | 12.2% | -107.9% |
| 2022 | $2.6B | $562M | $273M | $84M | 9.7% | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2025 |
|---|---|
| Total Revenue | 3,312.77 |
| Operating Revenue | 3,312.77 |
| Cost Of Revenue | 118.05 |
| Gross Profit | 3,194.72 |
| Operating Expense | 2,806.76 |
| Selling General And Administration | 2,064.20 |
| Total Expenses | 2,924.80 |
| Operating Income | 387.96 |
| EBITDA | -737.83 |
| Normalized EBITDA | 577.21 |
| EBIT | -927.08 |
| Interest Expense | 138.86 |
| Net Interest Income | -138.86 |
| Other Non Operating Income Expenses | - |
| Other Income Expense | -1,315.04 |
| Interest Expense Non Operating | 138.86 |
| Net Non Operating Interest Income Expense | -138.86 |
| Pretax Income | -1,065.94 |
| Tax Provision | 25.98 |
| Tax Rate For Calcs | 0 |
| Tax Effect Of Unusual Items | -276.16 |
| Net Income Continuous Operations | -1,091.92 |
| Net Income From Continuing And Discontinued Operation | -1,102.77 |
| Net Income From Continuing Operation Net Minority Interest | -1,102.77 |
| Net Income | -1,102.77 |
| Net Income Common Stockholders | -1,102.77 |
| Net Income Including Noncontrolling Interests | -1,091.92 |
| Normalized Income | -63.89 |
| Diluted NI Availto Com Stockholders | -1,102.77 |
| Basic Average Shares | 90.70 |
| Diluted Average Shares | 90.70 |
| Reconciled Depreciation | 189.25 |
| Reconciled Cost Of Revenue | 118.05 |
| Total Unusual Items | -1,315.04 |
| Total Unusual Items Excluding Goodwill | -1,315.04 |
| Minority Interests | -10.85 |
| Net Income Discontinuous Operations | - |
| Special Income Charges | -1,315.04 |
| Other Special Charges | 287.49 |
| Write Off | 1,007.89 |
| Impairment Of Capital Assets | - |
| Restructuring And Mergern Acquisition | 28.37 |
| Depreciation Amortization Depletion Income Statement | 189.25 |
| Depreciation And Amortization In Income Statement | 189.25 |
| General And Administrative Expense | 2,064.20 |
| Other Gand A | 195.48 |
| Salaries And Wages | 1,820.70 |
| Gain On Sale Of Ppe | 8.72 |
| Rent Expense Supplemental | 48.02 |
| Other Operating Expenses | 553.31 |
| Rent And Landing Fees | 48.02 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Acadia Healthcare Company, Inc.this co. | ACHC | $2.3B | -2.10 | 1.19 | -56.6% | -6.55 |
| Privia Health Group, Inc. | PRVA | $2.7B | 117.50 | 3.65 | 3.1% | 50.35 |
| Supernus Pharmaceuticals, Inc. | SUPN | $2.6B | -67.30 | 2.44 | -3.6% | 58.94 |
| TransMedics Group, Inc. | TMDX | $2.5B | 12.96 | 5.21 | 40.2% | 16.82 |
| Prestige Consumer Healthcare Inc. |
| 2021 |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| PBH |
| $2.2B |
| 11.31 |
| 1.14 |
| 10.1% |
| 9.47 |
| LeMaitre Vascular, Inc. | LMAT | $2.1B | 37.03 | 5.43 | 14.7% | 25.28 |
| Select Medical Holdings Corporation | SEM | $2.0B | 13.99 | 1.20 | 8.6% | 9.20 |
| Neogen Corporation | NEOG | $2.0B | -1.82 | 0.96 | -52.7% | -2.94 |
| ADMA Biologics, Inc. | ADMA | $1.8B | 12.59 | 3.87 | 30.8% | 9.31 |
| Peer Median | - | 12.78 | 3.05 | 9.3% | 13.14 | |